Unichem Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 04, 2025
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Unichem Laboratories held its 62nd AGM on August 4, 2025 via video conferencing, and all seven resolutions were passed with the required majority. Resolution 1 covered adoption of audited standalone and consolidated financial statements for FY ending March 31, 2025, and was approved with 100% of votes in favor (5,66,45,100 shares). Resolution 2 re-appointed Dr. Prakash A. Mody as a director (retiring by rotation), passing with 99.21% in favor. Resolutions 3, 4, and 5 approved material related party transactions involving holding company Ipca Laboratories and wholly owned subsidiary Unichem Pharmaceuticals (USA) Inc., each passing with 99.99% support. Resolution 6 appointed M/s Alwyn Jay & Co. as secretarial auditors for five years (FY2025-26 to FY2029-30), and Resolution 7 ratified ₹6,00,000 remuneration for cost auditors Kishore Bhatia Associates for FY ending March 31, 2026, both with 100% approval.
All resolutions passed comfortably with negligible dissent, confirming smooth governance and shareholder support for the company's direction, including its related party dealings with parent Ipca Laboratories. Director re-appointment and the new five-year secretarial auditor mandate provide continuity, and the approved RPTs formalize ongoing transactions with the holding company and US subsidiary.